Position in GILD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$296,267
-$30,555 QoQ
Shares Held
2,345
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,655
of 2,266 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pavion Blue Capital, LLC holds $13,787,434 across 7 Drug Manufacturers - General names. GILD ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
27,864 | $7,076,620 | |
| 2 | LLY |
ELI LILLY & Co
|
1,805 | $2,164,971 | |
| 3 | ABBV |
AbbVie Inc.
|
8,426 | $2,120,318 | |
| 4 | AMGN |
Amgen Inc
|
2,846 | $1,030,593 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
14,208 | $818,664 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
2,345 | $296,267 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,179 | $280,001 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $296,267 | 2,345 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $326,822 | 2,345 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $287,825 | 2,345 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $260,295 | 2,345 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $259,990 | 2,345 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $262,757 | 2,345 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $216,607 | 2,345 | Shares | Sole | 2025-02-04 | |
| 2023-03-31 | $202,446 | 2,440 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $209,474 | 2,440 | Shares | Sole | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||